Grifols, S. A., is a Spanish pharmaceutical company focusing on the development, manufacturing, and sale of therapeutic
Fantastic news! We've Found the answer you've been seeking!
Question:
Grifols, S. A., is a Spanish pharmaceutical company focusing on the development, manufacturing, and sale of therapeutic products. At the end of 2013, Grifols was rated "BB" by Standard & Poor's and considered to have a stable business risk profile.
Required
a. What is a credit rating and why would a potential investor in bonds be interested in a company's credit rating?
b. What type of factors does a credit rating agency consider in rating a company?
c. Compute funds from operations over debt and debt to EBITDA for 2012 and 2013 using the selected financial statement information above.
d. Research the financial risk rating by Standard and Poor's and use it as benchmark to asses the financial risk profile of the company for both years
Posted Date: